Page last updated: 2024-10-22

n-acetyltryptophan and Infarction, Middle Cerebral Artery

n-acetyltryptophan has been researched along with Infarction, Middle Cerebral Artery in 2 studies

N-acetyltryptophan : An N-acetylamino acid that is the N-acetyl derivative of tryptophan.

Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Turner, RJ2
Vink, R2
Helps, SC1
Thornton, E1

Other Studies

2 other studies available for n-acetyltryptophan and Infarction, Middle Cerebral Artery

ArticleYear
NK1 tachykinin receptor treatment is superior to capsaicin pre-treatment in improving functional outcome following acute ischemic stroke.
    Neuropeptides, 2014, Volume: 48, Issue:5

    Topics: Animals; Capsaicin; Infarction, Middle Cerebral Artery; Male; Motor Activity; Neurokinin-1 Receptor

2014
A substance P antagonist improves outcome when administered 4 h after onset of ischaemic stroke.
    Brain research, 2011, Jun-01, Volume: 1393

    Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Disease Models, Animal; Drug Administrati

2011